WallStSmart

IPG Photonics Corporation (IPGP)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

IPG Photonics Corporation generates 288% more annual revenue ($1.00B vs $258.90M). IPGP leads profitability with a 3.1% profit margin vs -15.5%. IPGP earns a higher WallStSmart Score of 51/100 (C-).

IPGP

Buy

51

out of 100

Grade: C-

Growth: 6.7Profit: 4.0Value: 3.3Quality: 7.8
Piotroski: 4/9Altman Z: 6.90

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

IPGPFair Value (-1.3%)

Margin of Safety

-1.3%

Fair Value

$109.53

Current Price

$118.92

$9.39 premium

UndervaluedFair: $109.53Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IPGP4 strengths · Avg: 9.0/10
EPS GrowthGrowth
69.3%10/10

Earnings expanding 69.3% YoY

Altman Z-ScoreHealth
6.9010/10

Safe zone — low bankruptcy risk

Price/BookValuation
2.4x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
17.1%8/10

17.1% revenue growth

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

IPGP4 concerns · Avg: 3.3/10
PEG RatioValuation
1.834/10

Expensive relative to growth rate

Return on EquityProfitability
1.5%3/10

ROE of 1.5% — below average capital efficiency

Profit MarginProfitability
3.1%3/10

3.1% margin — thin

Operating MarginProfitability
2.1%3/10

Operating margin of 2.1%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : IPGP

The strongest argument for IPGP centers on EPS Growth, Altman Z-Score, Price/Book. Revenue growth of 17.1% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : IPGP

The primary concerns for IPGP are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.9x leaves little room for execution misses. Thin 3.1% margins leave little buffer for downturns.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

IPGP profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SEMICONDUCTOR EQUIPMENT & MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

IPGP scores higher overall (51/100 vs 41/100) and 17.1% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

IPG Photonics Corporation

TECHNOLOGY · SEMICONDUCTOR EQUIPMENT & MATERIALS · USA

IPG Photonics is a manufacturer of fiber lasers.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?